Concepedia

Jinghai Wen

JW

7

Publications

509

Citations

7

H-Index

2000

Active since

Affiliations

Altor BioScience (United States)(Current)

Sylvester Comprehensive Cancer Center

University of Miami

Jinghai Wen is an author at Altor BioScience (United States) specializing in immunotherapy, immunology, and medicine.

Top concepts

Publications per year

2000–2015

7

Publications

7

Comparison of the Superagonist Complex, ALT-803, to IL15 as Cancer Immunotherapeutics in Animal Models

Peter R. Rhode, Jack O. Egan, Wenxin Xu et al. · Cancer Immunology Research · 2015 · 220 citations · Full text

, , +19

Antileukemic drugs increase death receptor 5 levels and enhance Apo-2L–induced apoptosis of human acute leukemia cells

Jinghai Wen, Ramadevi Nimmanapalli, Diep Nguyen et al. · Blood · 2000 · 184 citations

Targeting activity of a TCR/IL-2 fusion protein against established tumors

Jinghai Wen, Xiaoyun Zhu, Bai Liu et al. · Cancer Immunology Immunotherapy · 2008 · 31 citations · Full text

, , +6

Potent antitumor activity of a tumor-specific soluble TCR/IL-2 fusion protein

Heather J. Belmont, Shari A. Price‐Schiavi, Bai Liu et al. · Clinical Immunology · 2006 · 25 citations

, , +8

Antileukemic drugs increase death receptor 5 levels and enhance Apo-2L–induced apoptosis of human acute leukemia cells

Jinghai Wen, Ramadevi Nimmanapalli, Diep Nguyen et al. · Blood · 2000 · 21 citations

Rows per page

1–5 of 7